Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F16IL2 plus Paclitaxel in Metastatic Merkel Cell Carcinoma
NCT02054884Phase 2Terminated
- Sponsor
- Philogen
- Start
- Oct 2013
- Primary completion
- Dec 2016
- Countries
- 6
01
Overview
A Phase 2 trial of teleleukin in Merkel cell carcinoma (MCC), sponsored by Philogen. Started Oct 2013; status: terminated.
02
Drugs
teleleukin
03
Conditions
Merkel cell carcinoma (MCC)
Beyond the preview
Go deeper on NCT02054884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054884.